Open Access Pre-publication history

A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia

David H Adams*, Bruce J Kinon, Simin Baygani, Brian A Millen, Isabella Velona, Sara Kollack-Walker and David P Walling

BMC Psychiatry 2013, 13:143  doi:10.1186/1471-244X-13-143

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 25 Apr 2012
Reviewer's Report Felice Iasevoli 16 Aug 2012
Reviewer's Report Jason Uslaner 20 Aug 2012
Reviewer's Report Wen-Jun Gao 24 Aug 2012
Reviewer's Report Bita Moghaddam 30 Aug 2012
Resubmission - Version 2 Manuscript Author's comment 17 Jan 2013
Reviewer's Report Felice Iasevoli 09 Feb 2013
Reviewer's Report Jason Uslaner 12 Feb 2013
Resubmission - Version 3 Manuscript Author's comment 08 May 2013
Editorial acceptance 15 May 2013
Published 22 May 2013